Literature DB >> 20399758

Effects of human OEC-derived cell transplants in rodent spinal cord contusion injury.

Catherine Anne Gorrie1, Ian Hayward, Nicholas Cameron, Gajan Kailainathan, Neilan Nandapalan, Ratneswary Sutharsan, Jennifer Wang, Alan Mackay-Sim, Phil M E Waite.   

Abstract

Numerous reports indicate that rodent olfactory ensheathing cells (OECs) assist in spinal cord repair and clinical trials have been undertaken using autologous transplantation of human olfactory ensheathing cells (hOECs) as a treatment for spinal cord injury. However, there are few studies investigating the efficacy of hOECs in animal models of spinal cord injury. In this study hOECs were derived from biopsies of human olfactory mucosa, purified by culture in a serum-free medium containing neurotrophin-3, genetically labelled with EGFP, and stored frozen. These hOEC-derived cells were thawed and transplanted into the spinal cord injury site 7 days after a moderate contusion injury of the spinal cord at thoracic level T10 in the athymic rat. Six weeks later the animals receiving the hOEC-derived transplants had greater functional improvement in their hindlimbs than controls, assessed using open field (BBB scale) and horizontal rung walking tests. Histological analysis demonstrated beneficial effects of hOEC-derived cell transplantation: reductions in the volume of the lesion and the cavities within the lesion. The transplanted cells were located at the periphery of the lesion where they integrated with GFAP-positive astrocytes resulting in a significant reduction of GFAP staining intensity adjacent to the lesion. Although their mechanism of action is unclear we conclude that hOEC-derived cell transplants improved functional recovery after transplantation into the contused spinal cord, probably by modulating inflammatory responses and reducing secondary damage to the cord. (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20399758     DOI: 10.1016/j.brainres.2010.04.019

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  22 in total

1.  Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?

Authors:  Aileen J Anderson; Daniel L Haus; Mitra J Hooshmand; Harvey Perez; Christopher J Sontag; Brian J Cummings
Journal:  Regen Med       Date:  2011-05       Impact factor: 3.806

2.  Optimal Preparation of Formalin Fixed Samples for Peptide Based Matrix Assisted Laser Desorption/Ionization Mass Spectrometry Imaging Workflows.

Authors:  Matthew B O'Rourke; Matthew P Padula; Caine Smith; Priscilla Youssef; Stuart Cordwell; Paul Witting; Greg Sutherland; Ben Crossett
Journal:  J Vis Exp       Date:  2018-01-16       Impact factor: 1.355

3.  Transplantation of human glial restricted progenitors and derived astrocytes into a contusion model of spinal cord injury.

Authors:  Ying Jin; Birgit Neuhuber; Anita Singh; Julien Bouyer; Angelo Lepore; Joseph Bonner; Tim Himes; James T Campanelli; Itzhak Fischer
Journal:  J Neurotrauma       Date:  2011-03-24       Impact factor: 5.269

4.  Adipose-Derived Stem Cells Expressing the Neurogenin-2 Promote Functional Recovery After Spinal Cord Injury in Rat.

Authors:  Linjun Tang; Xiaocheng Lu; Ronglan Zhu; Tengda Qian; Yi Tao; Kai Li; Jinyu Zheng; Penglai Zhao; Shuai Li; Xi Wang; Lixin Li
Journal:  Cell Mol Neurobiol       Date:  2015-08-18       Impact factor: 5.046

5.  Safety of human neural stem cell transplantation in chronic spinal cord injury.

Authors:  Katja M Piltti; Desiree L Salazar; Nobuko Uchida; Brian J Cummings; Aileen J Anderson
Journal:  Stem Cells Transl Med       Date:  2013-11-04       Impact factor: 6.940

Review 6.  Electroactive Scaffolds to Improve Neural Stem Cell Therapy for Spinal Cord Injury.

Authors:  Anthea R Mutepfa; John G Hardy; Christopher F Adams
Journal:  Front Med Technol       Date:  2022-02-22

Review 7.  The culture of olfactory ensheathing cells (OECs)--a distinct glial cell type.

Authors:  Jennifer R Higginson; Susan C Barnett
Journal:  Exp Neurol       Date:  2010-09-15       Impact factor: 5.330

8.  Co-transplantation of olfactory ensheathing cells from mucosa and bulb origin enhances functional recovery after peripheral nerve lesion.

Authors:  Nicolas Guérout; Alexandre Paviot; Nicolas Bon-Mardion; Célia Duclos; Damien Genty; Laetitia Jean; Olivier Boyer; Jean-Paul Marie
Journal:  PLoS One       Date:  2011-08-03       Impact factor: 3.240

9.  Transplantation of neuronal-primed human bone marrow mesenchymal stem cells in hemiparkinsonian rodents.

Authors:  Melissa L M Khoo; Helen Tao; Adrian C B Meedeniya; Alan Mackay-Sim; David D F Ma
Journal:  PLoS One       Date:  2011-05-23       Impact factor: 3.240

Review 10.  Cellular treatments for spinal cord injury: the time is right for clinical trials.

Authors:  Michael G Fehlings; Reaz Vawda
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.